ArticleReports of biochemistry & molecular biology2022

A CB2 Receptor Agonist Reduces the Production of Inflammatory Mediators and Improves Locomotor Activity in Experimental Autoimmune Encephalomyelitis.

Karim Parastouei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.